首页|6-氮杂吲哚类化合物的合成及抗胰腺癌活性评价

6-氮杂吲哚类化合物的合成及抗胰腺癌活性评价

扫码查看
通过筛选内部化合物库,鉴定出了具有一定抗胰腺癌活性的片段。经系统改造合成了 4类共计18个化合物,并进行了抗胰腺癌活性评价。化合物 Ⅱ-1(IC50=6。40±0。34 μmol·L-1)和 Ⅱ-2(IC50=7。15±0。51 μmol·L-1)活性表现突出。随后用细胞划痕实验及侵袭实验评价了 Ⅱ-1的抗迁移能力及侵袭能力,结果显示,Ⅱ-1具有良好的抗迁移能力及突出的抗侵袭能力。利用分子对接技术及分子动力学模拟技术,锁定了 Ⅱ-1的靶点为双特异性酪氨酸磷酸化调控激酶1A(DYRK1A)。经酶活测试Ⅱ-1和Ⅱ-2分别有48%及32%酶抑制能力。
Synthesis and activity evaluation of 6-azazindole derivatives for pancreatic cancer therapy
Fragment with some anti-pancreatic cancer activity was identified by screening our internal chemical library.Eighteen compounds in 4 classes were synthesized by systematic modification and their anti-pancreatic cancer activity were evaluated.Ⅱ-1(IC50=6.40±0.34 μmol·L-1)and Ⅱ-2(IC50=7.15±0.51 μmol·L-1)exhibited outstanding activity.Subsequently,the anti-migration ability and invasion ability of Ⅱ-1 was evaluated by wound healing assay and invasion assay,Ⅱ-1 exhibited good anti-migration ability and outstanding anti-invasion ability.Using molecular docking technology and molecular dynamics simulation technology,the potential target was locked on bispecific tyrosine phosphorylation regulates kinase 1A(DYRK1A).By enzyme activity testing,the inhibitory capacity of Ⅱ-1 and Ⅱ-2 was 48%and 32%,respectively.

6-azaindoleanti-pancreatic cancerbispecific tyrosine phosphorylation regulates kinase 1Asynthesisanti-proliferation

曹阳、李前、王亚玲、崔文慧、钱晨亮、司鑫鑫

展开 >

南京大学化学化工学院,江苏南京 210093

江苏海洋大学,江苏省海洋药物活性分子筛选重点实验室,江苏连云港 222005

6-氮杂吲哚 抗胰腺癌 双特异性酪氨酸磷酸化调控激酶1A 合成 抗增殖

江苏海洋大学研究生科研与实践创新计划项目中国博士后科学基金

KYCX2022-312023M741444

2024

药学学报
中国药学会 中国医学科学院药物研究所

药学学报

CSTPCD北大核心
影响因子:1.274
ISSN:0513-4870
年,卷(期):2024.59(10)